AMYLIN PHARMACEUTICALS INC Operating Income
AMYLIN PHARMACEUTICALS INC reported Operating Income of -$29.88 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2012-08-03
- AMYLIN PHARMACEUTICALS INC operating income (loss) for the quarter ending 2012-06-30 was -$29.88M.
- AMYLIN PHARMACEUTICALS INC operating income (loss) for the quarter ending 2012-03-31 was -$54.33M.
- AMYLIN PHARMACEUTICALS INC operating income (loss) for the quarter ending 2011-12-31 was -$429.75M.
- AMYLIN PHARMACEUTICALS INC operating income (loss) for the quarter ending 2011-09-30 was -$7.78M.
- AMYLIN PHARMACEUTICALS INC operating income (loss) for fiscal 2011 was -$491.46M.
- AMYLIN PHARMACEUTICALS INC operating income (loss) for fiscal 2010 was -$126.74M.
- AMYLIN PHARMACEUTICALS INC operating income (loss) for fiscal 2009 was -$173.35M.
- AMYLIN PHARMACEUTICALS INC operating income (loss) for fiscal 2008 was -$297.22M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2012-06-30 | -$29.88M 10-Q · filed 2012-08-03 | -$84.21M 10-Q · filed 2012-08-03 | -$513.96M derived: sum of 3 quarters · filed 2012-08-03 | -$521.75M derived: sum of 4 quarters · filed 2012-08-03 |
| 2012-03-31 | -$54.33M 10-Q · filed 2012-05-07 | -$484.09M derived: sum of 2 quarters · filed 2012-05-07 | -$491.87M derived: sum of 3 quarters · filed 2012-05-07 | -$516.71M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-12-31 | -$429.75M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | -$437.54M derived: sum of 2 quarters · filed 2012-02-22 | -$462.38M derived: sum of 3 quarters · filed 2012-08-03 | -$491.46M 10-K · filed 2012-02-22 |
| 2011-09-30 | -$7.78M 10-Q · filed 2011-10-28 | -$32.63M derived: sum of 2 quarters · filed 2012-08-03 | -$61.70M 10-Q · filed 2011-10-28 | -$72.01M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-06-30 | -$24.84M 10-Q · filed 2012-08-03 | -$53.92M 10-Q · filed 2012-08-03 | -$64.23M derived: sum of 3 quarters · filed 2012-08-03 | -$109.26M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-03-31 | -$29.08M 10-Q · filed 2012-05-07 | -$39.39M derived: sum of 2 quarters · filed 2012-05-07 | -$84.42M derived: sum of 3 quarters · filed 2012-05-07 | -$122.98M derived: sum of 4 quarters · filed 2012-05-07 |
| 2010-12-31 | -$10.31M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | -$55.34M derived: sum of 2 quarters · filed 2012-02-22 | -$93.90M derived: sum of 3 quarters · filed 2012-02-22 | -$126.74M 10-K · filed 2012-02-22 |
| 2010-09-30 | -$45.03M 10-Q · filed 2011-10-28 | -$83.59M derived: sum of 2 quarters · filed 2011-10-28 | -$116.43M 10-Q · filed 2011-10-28 | -$163.68M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-06-30 | -$38.56M 10-Q · filed 2011-08-08 | -$71.40M 10-Q · filed 2011-08-08 | -$118.65M derived: sum of 3 quarters · filed 2012-02-22 | -$141.05M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-03-31 | -$32.84M 10-Q · filed 2011-05-05 | -$80.09M derived: sum of 2 quarters · filed 2012-02-22 | -$102.49M derived: sum of 3 quarters · filed 2012-02-22 | -$160.64M derived: sum of 4 quarters · filed 2012-02-22 |
| 2009-12-31 | -$47.25M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | -$69.65M derived: sum of 2 quarters · filed 2012-02-22 | -$127.80M derived: sum of 3 quarters · filed 2012-02-22 | -$173.35M 10-K · filed 2012-02-22 |
| 2009-09-30 | -$22.40M 10-Q · filed 2010-11-08 | -$80.55M derived: sum of 2 quarters · filed 2010-11-08 | -$126.10M 10-Q · filed 2010-11-08 | |
| 2009-06-30 | -$58.15M 10-Q · filed 2010-08-05 | -$103.70M 10-Q · filed 2010-08-05 | ||
| 2008-12-31 | -$297.22M 10-K · filed 2011-02-25 |